Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director SHAH MAHENDRA
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director ONETTO NICOLE
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director O'CALLAGHAN BRIAN
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lee Frank D.
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director LAPORTE KATHLEEN
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEALY JAMES
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Berner Laura
Bolt Biotherapeutics | 8-K: Current report
Bolt Biotherapeutics | DEFA14A: Others
Bolt Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Officer Nemec Sarah
Bolt Biotherapeutics | 10-Q: Quarterly report
Bolt Biotherapeutics | 8-K: Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
Bolt Biotherapeutics | DEFA14A: Others
Bolt Biotherapeutics | DEF 14A: Definitive information statements
Bolt Biotherapeutics | ARS: Annual Report to Security Holders
Bolt Biotherapeutics | 10-K: Annual report
Bolt Biotherapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Bolt Biotherapeutics | 8-K: Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yonehiro Grant
Bolt Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Perez Edith A.
No Data